36 percent of millennials bear disproportionate burden of chronic illnesses: Redcliffe Labs study
Redcliffe Labs, a pan-India omnichannel diagnostics provider, has released a study unveiling stark generational differences in chronic disease prevalence and healthcare access patterns. A recent study conducted with a sample size of over 1.5 million found that millennials bear a disproportionate burden of chronic illnesses compared to their Gen Z counterparts.
Alarmingly, 36% of millennials are diagnosed with chronic conditions such as diabetes, hypertension, cardiovascular diseases and obesity. In contrast, only 12% of the Gen Z population face similar health challenges. This threefold difference underscores the pressing need for targeted interventions and preventative measures tailored to millennials.
Access to healthcare services, including preventive screenings and vaccinations, varies significantly between Gen Z and millennials. While millennials are more susceptible to chronic diseases, Gen Z often face barriers to accessing timely healthcare interventions. Closing this gap is paramount to ensure equitable healthcare access for all generations.
The study also highlighted a positive trend: the rising prevalence of chronic diseases has led to a paradigm shift from reactive test checkups to proactive preventive health screenings. There is a noticeable uptick in the propensity to seek preventive health checkups across genders, with approximately 50% of women now opting for preventative diagnosis. Notably, more residents in Tier 1 and 2 cities are proactively seeking these preventive tests due to improved awareness and accessibility compared to those living in rural areas.
Dr. Sohini Sengupta, Medical Laboratory Director, Redcliffe Labs, said, "This generational health divide is concerning and cannot be ignored. Millennials' higher chronic disease rates likely stem from lifestyle factors like poor diet, lack of exercise, stress, and substance abuse. However, limited Gen Z preventive screening may also underestimate their disease burden. At Redcliffe Labs, we are committed to making healthcare more accessible, reliable, and affordable for all generations. By enhancing access to preventive screening services through our pan-India network and driving targeted awareness, we aim to bridge this divide. Early intervention is the key to reducing healthcare costs and improving outcomes for chronic diseases.”
As India grapples with a growing health crisis, understanding and addressing the divergent health trends among different generations is paramount. By leveraging data-driven insights and embracing proactive healthcare strategies, Redcliffe Labs aims to bridge the health divide, ensuring a healthier future for all.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.